Prescription drug · ANDA
Teriparatide NDC 0093-1106
Teriparatide acetate 250 ug/mL · Injection, Solution · Subcutaneous · Teva Pharmaceuticals USA, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0093-1106-16 | 0009311061600093110616 | 1 SYRINGE in 1 CARTON (0093-1106-16) / 2.24 mL in 1 SYRINGEMarketed from Dec 18, 2023 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Teriparatide
- Generic name (nonproprietary)
- teriparatide
- Active ingredients
- Teriparatide acetate — 250 ug/mL
- Dosage form
- Injection, Solution
- Route
- Subcutaneous
- Labeler
- Teva Pharmaceuticals USA, Inc.NDC labeler code 0093
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 208569
- Marketing start
- Listing expires
- Other FDA classes
- Parathyroid Hormone (Chemical structure)
- Identifiers
- Product ID 0093-1106_8cf1823b-f18f-49c3-9c97-6e6a8c35df1eSPL ID 8cf1823b-f18f-49c3-9c97-6e6a8c35df1e
- Pharmacologic class
- Parathyroid Hormone Analog
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N400093110616followed by a unit qualifier and the quantityPackage 00093-1106-16. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
The FDA listing for this product does not reference a label (SPL) set.
About NDC 0093-1106
- What is NDC 0093-1106?
- 0093-1106 is the product NDC for Teriparatide, Teriparatide acetate 250 ug/mL injection, solution, listed with the FDA by Teva Pharmaceuticals USA, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Teriparatide.
- What is the active ingredient?
- Teriparatide acetate.
- Who is the labeler?
- Teva Pharmaceuticals USA, Inc., NDC labeler code 0093. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Teriparatide?
- 6 other product NDCs are listed under this name. See all Teriparatide NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Teriparatide products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Teriparatide | Teriparatide 250 ug/mL | InjectionSubcutaneous | BluePoint Laboratories | 68001-693 | 68001-0693-76 |
| Teriparatide | Teriparatide 250 ug/mL | InjectionSubcutaneous | Amphastar Pharmaceuticals, Inc. | 0548-2311 | 00548-2311-00 |
| Teriparatide | Teriparatide 250 ug/mL | Injection, SolutionSubcutaneous | Prasco Laboratories | 66993-989 | 66993-0989-28 |
| Teriparatide | Teriparatide 250 ug/mL | Injection, SolutionSubcutaneous | Prasco Laboratories | 66993-495 | 66993-0495-28 |
| Teriparatide | Teriparatide 250 ug/mL | Injection, SolutionSubcutaneous | Apotex Corp. | 60505-6188 | 60505-6188-00 |
| teriparatide | Teriparatide 250 ug/mL | Injection, SolutionSubcutaneous | Alvogen, Inc. | 47781-652 | 47781-0652-89 |